Marco Krengli
Papers
1
Total Citations
18
H-Index
1
About
Dr. Marco Krengli is a leading figure in radiation oncology, with a focused expertise in hadrontherapy and the clinical application of advanced particle beam technologies. His most impactful work centers on the pioneering implementation of scanned proton beams, as demonstrated by his seminal 2013 paper on the initial clinical experience at the Italian National Center for Hadrontherapy (CNAO). This work, which has garnered 18 citations, documented the first patient treatments and early toxicity data from CNAO’s prospective Phase II protocols, marking a critical milestone in the clinical validation of scanned proton therapy for challenging tumors like chondrosarcomas. Dr. Krengli’s contributions have been instrumental in establishing the safety and feasibility of this precise radiation modality, directly influencing treatment protocols for skull-base and spinal malignancies. Beyond this landmark study, his research portfolio consistently addresses the optimization of particle therapy, bridging the gap between technological innovation and patient outcomes. His leadership at CNAO has positioned him as a key authority in the field, shaping how modern radiation oncology integrates advanced beam delivery to minimize collateral damage while maximizing tumor control.
Research Focus
Key Achievements
Top Papers
- 1